FRANCHINI INDRANI LALL (EVP, Chief Compliance Officer) reported 1 transaction at ALEXION PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/23/2021ACC: 0000899866-21-000066
Officer· EVP, Chief Compliance Officer
Since Nov 2018
-141.24K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
141.24K disposed
Non-Derivative Transactions1
Common Stock, par value $.0001 per share
Direct
Shares
−116.08K
Price / share
—
Trade value
—
% of position
New position
7/21/2021
116.08K→0.00
Total
Net shares
−116.08K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.0001 per share Direct | 7/21/2021 | D · Disposition | −116.08K | — | — | New position | 116.08K | 0.00 |
| Total | −116.08K | $0.00 | ||||||
Derivative Transactions1
Option to Purchase Common Stock
Direct
Converts to
Common Stock, par value $.0001 per share
25.16K shares
Shares
−25.16K
Strike price
100.14
Held after
0.00
Exercisable
—
7/21/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock Direct | Common Stock, par value $.0001 per share25.16K shares | 7/21/2021 | D · Disposition | −25.16K | 100.14 | — | 0.00 |